Trials / Completed
CompletedNCT05059600
A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
Assessment of Safe-use Conditions for Administration of ZULRESSO in a Home Setting
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Supernus Pharmaceuticals, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study was to evaluate whether the safe-use conditions for administration of brexanolone (ZULRESSO®) can be implemented in a home setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZULRESSO® | Intravenous infusion of ZULRESSO®. |
Timeline
- Start date
- 2021-10-08
- Primary completion
- 2022-07-14
- Completion
- 2022-07-14
- First posted
- 2021-09-28
- Last updated
- 2025-09-15
- Results posted
- 2023-07-19
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05059600. Inclusion in this directory is not an endorsement.